SAN FRANCISCO / ACCESSWIRE / June 27, 2024 / Form Bio, the provider of advanced computational life sciences technology and PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate ...
Partnership leverages AI-powered genome design to optimize AAV constructs, accelerate lead candidate selection, and improve drug substance manufacturability for rare and ultra-rare neuromuscular ...
Top challenges, opportunities, and investment areas for data science and AI within life sciences. Framework-level thinking for introducing and implementing AI and advanced data science in scientific ...
In the midst of an ongoing growth strategy, Form Bio hired Mark Swendsen as Chief Revenue Officer. The computational life sciences platform company, which officially launched late last month, is ...
When George Church, PhD, and co-founders established Colossal Biosciences, they envisioned applying their advancements in CRISPR gene editing to the loss of biodiversity, species preservation, and ...
Integrated solution aims to reduce time and cost to lead candidates, advancing safer and more effective gene therapies to patients faster. This partnership brings together GENEWIZ's industry-leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results